February 17, 2026

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Navigating a 10.78% Upside Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands as a notable player within the Healthcare sector, specifically in the specialty and generic drug manufacturing industry. With its headquarters in Rancho Cucamonga, California,..

AdaptHealth Corp. (AHCO) Stock Analysis: Healthcare Giant Set for Potential 31% Upside

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, specializes in the distribution of home medical equipment and related services across the United States. With a market capitalization..

Enovis Corporation (ENOV) Stock Analysis: Captivating 107% Upside Potential Amid Strong Buy Ratings

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector specializing in medical devices, is capturing the attention of investors with its notable potential upside of 107.12%. This Wilmington,..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 24% Potential Upside in the Healthcare Sector

Bausch Health Companies Inc. (NYSE: BHC) stands as a prominent player in the healthcare sector, specifically within the drug manufacturing industry. With its headquarters in Laval, Canada, Bausch Health has..

AtriCure, Inc. (ATRC) Stock Analysis: Analyst Ratings Suggest a 57.56% Upside Potential

AtriCure, Inc. (NASDAQ: ATRC) stands at the forefront of the healthcare sector, specifically within the niche of medical instruments and supplies. Headquartered in Mason, Ohio, the company specializes in developing..

Haemonetics Corporation (HAE) Stock Analysis: Is a 52% Upside Within Reach for This Medical Device Innovator?

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its substantial potential upside. With a market capitalization of $2.7..

GRAIL, Inc. (GRAL) Stock Analysis: 17.95% Potential Upside in the Healthcare Diagnostics Sector

Investors with an eye on the healthcare sector should pay close attention to GRAIL, Inc. (GRAL), a powerhouse in the diagnostics and research industry with a market capitalization of $3.8..

Apogee Therapeutics (APGE) Stock Analysis: A Biotech Gem with 53.86% Potential Upside

Apogee Therapeutics, Inc. (NASDAQ: APGE) is carving out a distinctive niche in the biotechnology sector, with its innovative approach to treating complex inflammatory and immunology conditions. Despite the company’s early..

LivaNova PLC (LIVN) Stock Analysis: A Promising 10.94% Upside in the Medical Devices Sector

Investors eyeing opportunities in the healthcare sector might want to take a closer look at LivaNova PLC (NASDAQ: LIVN), a key player in the medical devices industry. With a market..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A 25% Upside Potential in the Biotech Sector

MoonLake Immunotherapeutics (NASDAQ: MLTX) stands out in the biotechnology sector with its ambitious pipeline and considerable upside potential. Headquartered in Zug, Switzerland, MoonLake is a clinical-stage biotech firm dedicated to..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Navigating Current Valuations with Strong Revenue Growth

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a notable player in the biotechnology sector, is currently capturing investor interest with its strong revenue growth and strategic focus on rare diseases. Headquartered in..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Evaluating a 31.79% Potential Upside in the Buprenorphine Market

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV), a prominent player in the healthcare sector specializing in drug manufacturing, presents a compelling investment opportunity anchored in the burgeoning demand for opioid dependence treatments...

Novavax, Inc. (NVAX) Stock Analysis: Evaluating a 48% Potential Upside in the Biotech Sector

As investors navigate the intricate landscape of the biotechnology sector, Novavax, Inc. (NASDAQ: NVAX) emerges as a compelling player with a unique proposition. With a market capitalization of $1.41 billion,..

Artivion, Inc. (AORT) Stock Analysis: Investors Eye 40.52% Potential Upside in Medical Device Innovator

Artivion, Inc. (AORT), a notable player in the healthcare sector specializing in medical devices, has captured investors’ attention with its promising growth trajectory and significant potential upside. With a current..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unpacking an 84.25% Potential Upside in the Spinal Devices Market

Alphatec Holdings, Inc. (ATEC) is making waves in the medical devices sector with its innovative approach to the surgical treatment of spinal disorders. Headquartered in Carlsbad, California, this healthcare company..

Immunocore Holdings plc (IMCR) Stock Analysis: A Biotech With Over 100% Potential Upside

Immunocore Holdings plc (NASDAQ: IMCR) stands out in the biotechnology sector, not just for its innovative approach to immunotherapies but also for the striking potential upside it offers to investors...

Arrowhead Pharmaceuticals (ARWR) Investor Outlook: Exploring the 27.49% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a beacon in the biotechnology industry, has been drawing attention with its remarkable growth trajectory and innovative pipeline. With a market capitalization of $8.94 billion,..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a Massive 89.92% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the U.S. healthcare sector, has recently captured the attention of investors with its impressive growth trajectory and substantial potential upside. With..

Neogen Corporation (NEOG) Stock Analysis: Navigating a 6.64% Potential Upside Amidst Financial Challenges

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector’s diagnostics and research industry, is positioning itself for growth despite current financial hurdles. With a market capitalization of $2.38..

Jubilee’s copper strategy gains definition as Zambia platform expands

A streamlined copper strategy in Zambia is reshaping Jubilee’s investment case around focused growth and operational delivery...
Search

Funds

February 17, 2026

Jubilee’s copper strategy gains definition as Zambia platform expands

A streamlined copper strategy in Zambia is reshaping Jubilee’s investment case around focused growth and operational delivery...
Search

Funds

February 17, 2026

FTSE 100

Funds